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INTRODUCTION
Endometrial cancer is the most common gynecologic
malignancy known worldwide. Its occurrence is in-
creasing in the developed countries. According to the
American Cancer Society, there were an estimated
40,100 new cases and 7,470 deaths due to endometrial
cancer in 2008.1,2
Endometrial cancer is the fourth common cancer
in woman after breast, lung and colorectal cancer. The
risk for women to be diagnosed with endometrial can-
cer is approximately 2.45%.3,4
In Indonesia, according to the previous research of
endometrial cancer in Dr. Cipto Mangunkusumo Hos-
pital Jakarta, was found the prevalence of endometrial
cancer were 7.2 cases in a year. The age of patients
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Objective: The purpose of this study was to determine the cor-
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Result: The prevalence of endometrial cancer from 1997 to 2006
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in 30 samples. Decreased E-Cadherin and β1-integrin expression
was associated with the depth of myometrial invasion, pelvic lymph
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differentiation in resectable endometrial cancer patients.
Conclusion: Decreased E-Cadherin and β1-integrin expression
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Abstrak
Tujuan: Penelitian ini dibuat untuk membuktikan apakah penu-
runan ekspresi E-Cadherin dan β1-integrin pada penderita kanker
endometrium berhubungan dengan kejadian kedalaman invasi mio-
metrium dan metastasis kelenjar getah bening pelvis.
Metode: Ini adalah penelitian retrospektif. Dilakukan pemerik-
saan ekspresi E-Cadherin dan β1-integrin secara imunohistokimia
pada penderita kanker endometrium yang telah dioperasi tahun
1997 - 2006 di Rumah Sakit Dr. Cipto Mangunkusumo dan mencari
hubungan dengan kejadian invasi miometrium dan metastasis ke-
lenjar getah bening.
Hasil: Kejadian kanker endometrium tahun 1997 - 2006 di Ru-
mah Sakit Dr. Cipto Mangunkusumo adalah 7,0 pertahun. Dari 64
penderita kanker endometrium hanya 36 yang ditemukan blok pa-
rafinnya dan hanya 30 sampel yang dapat diperiksa ekspresi E-
Cadherin dan β1-integrin secara imunohistokimia. Diperoleh hasil
bahwa penurunan ekspresi E-Cadherin dan β1-integrin berhubung-
an dengan kejadian invasi miometrium, metastasis KGB pelvis,
LVSI dan derajat diferensiasi sel penderita kanker endometrium.
Kesimpulan: Ekspresi E-Cadherin dan β1-integrin yang menu-
run berhubungan dengan kedalaman invasi miometrium dan metas-
tasis kelenjar getah bening pelvis.
[Maj Obstet Ginekol Indones 2010; 34-3: 136-42]
Kata kunci: E-Cadherin, β1-integrin, invasi miometrium, metas-
tasis kelenjar getah bening pelvis
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tend to be younger than the age of patients in Europe
and Western countries.3,5
Epidemiological, clinical, and experimental data
indicated that the incidence of endometrial cancers
were highly dependent on age, most of patient at 60
years of age. Approximately 75 percent of endome-
trial cancers occur red in postmenopausal women and
the rest appeared among the premenopausal women.
One of the mayor issues for young women with en-
dometrial cancers are to maintain reproductive func-
tion and conservative treatment may be considered.
But conservative treatment can only be done for en-
dometrial cancer without invasion.
Hence the first incidence of endometrial cancer,
there were no specific and accurate tools to detect
endometrial cancer invasion and metastasis yet. To
detect the depth of myometrial invasion pelvic ultra-
sonography, computerized tomography imaging and
magnetic resonance imaging were used. However the
accuracy of pelvic ultrasonography was only 69% and
the accuracy of magnetic resonance imaging (MRI)
was 74% in endometrial cancer stage I.6
Since we try to find another modality to detect the
depth of myometrial invasion and metastasis in the
reproductive women who suffer from endometrial
cancer. The expression of cell adhesion molecules
such as integrin and cadherin can be used to predict
the invasion and metastasis of endometrial cancer.
The cases of endometrial cancer without invasion and
metastasis to myometrial may be considered to main-
tain the reproductive function in woman who still
wants to get children.
One of the most characteristic features of cancer
cell is invasion and metastasis. The invasion and me-
tastasis themselves consist of sequential steps invol-
ving host-tumor interaction.7
Many gene play a significant role in the invasion
and metastasis, such as E-Cadherin and β1-integrin as
cell adhesion molecules. The decreased cell adhesion
molecules such as E-Cadherin and β1-integrin allows
cancer cells to leave the primary cancer nest. Detach-
ment of cancer cells from the primary tumor mass
may involved decreased expression of adhesion mo-
lecule such as E-Cadherin and β1-integrin.7,8
The roles of E-Cadherin in the invasion and me-
tastatic processes had been shown in the research of
breast and prostate cancer. There was a strong corre-
lation between the lost of E-Cadherin expression with
the invasion and metastatic processes.8
Moreover, invasion and metastatic processes, which
are the most life-threatening properties of malignant
tumors consist of sequential steps involving host-
tumor interactions. The cancer cells first leave the pri-
mary cancer nest then invade the surrounding host
tissue, enter the circulation, lodge in a distant vascular
bed, extravasate into target organ and proliferate. The
cancer cells can interact with collagen, fibronectin and
laminin through the binding of these extracellular ma-
trix (ECM) components to integrin.7
The integrins are a family of cell-surface glycopro-
teins that act as receptors for extracellular matrix pro-
tein, or as membrane bound counter-receptors on ot-
hers cells. Integrin-mediated cell-ECM adhesion sites
are complex specialized structures term focal contacts
or focal adhesions. Each integrin is a heterodimer that
contains an α and a β subunit with each subunit ha-
ving a large extracellular domain, a single membrane-
spanning region. The integrins receptors play a central
role in cell migration through their roles as adhesive
receptors for both other cells. While the extracellular
matrix components play a significant role in the con-
trol of tumor cell invasion and metastasis.7-9
The present study demonstrated statistically signifi-
cant that β1-integrin plays a critical role in the inva-
sion and metastatic process. These results are in
agreement with previous report on the mice that was
injected by β1-integrin. The β1-integrin was believed
to have block the melanoma progression into lymph
nodes and blood vascular system, and also blocked
the spread of the tumor to distant metastasis.10
METHOD
The design of this study was cross sectional study.
We enrolled fifty six patients with endometrial carci-
noma and were treated between June 1997 and No-
vember 2006. None of the patients received chemo-
therapy or radiotherapy before surgery. All patients
were treated by total hysterectomy, bilateral salpingo-
oophorectomy, peritoneal cytology, and pelvic and
para-aortic lymph node sampling as indicated.
The study was conducted for 6 months in the Sub-
division of Oncology-Gynecology, Department of
Obstetrics and Gynecology and Department of Pa-
thology, Medical Faculty of Indonesia University/Dr.
Cipto Mangunkusumo Hospital, Jakarta.
From 56 patients, only 36 paraffin blocks could be
found at the Department of Pathology, Medical Fa-
culty of Indonesia University/Dr. Cipto Mangunku-
sumo Hospital, Jakarta. However, only 30 paraffin
blocks were capable for immunostaining on E-Cadherin
and β1-integrin expression. Prior to E-Cadherin and
β1-integrin staining, two experienced pathologists
were blinded to the clinical data collected. The his-
tologic grade, the depth of myometrial invasion, and
the clinical stage were classified as recommended by
the International Federation of Gynecology and Ob-
stetrics (FIGO) of 1995. The staining results were
compared to histologic and clinical data. The his-
tologic features of the 30 endometrial cancer’s pa-
tients are shown in Table 1.
The samples size calculation formula using two
tailed unpaired proportion with the number of samples
were at least 12 samples, to determine the correlation
of decreased E-Cadherin and β1-integrin expression
in resectable endometrial cancer with the depth of myo-
metrial invasion and pelvic lymph node metastasis.
There were inclusion and exclusion criteria in this
study. The inclusion criterias were patients who had
undergone surgery at Subdivision of Oncology-
Gynecology, Department of Obstetrics and Gynecol-
ogy, Medical Faculty of Indonesia University/Dr.
Cipto Mangunkusumo Hospital, Jakarta. The medical
record of patients with endometrial cancer were ob-
tained at the polyclinic of Oncology-Gynecology,
Department of Obstetrics and Gynecology, while the
paraffin blocks and pathological records were avail-
able at Department of Pathology.
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The exclusion criterias were damaged paraffin
blocks, stocks fall during staining, necrotic cells. In-
complete data from the Subdivision of Oncology-
Gynecology of Obstetrics and Gynecology Depart-
ment, Department of Obstetrics and Gynecology and
Department of Pathology, Medical Faculty of Indone-
sia University/Dr. Cipto Mangunkusumo Hospital,
Jakarta.
There were independent and dependent criterias in
this study. Independent criterias were E-Cadherin and
β1-integrin. Whereas dependent criterias were lymp
nodes metastasis, myometrial invasion, LVSI (lym-
phovascular space involvement), and degree of dif-
ferentiation.
The expression of E-Cadherin and β1-integrin were
examined by immunohistochemical technique from
endometrial tissue in paraffin blocks. The paraffin
blocks section were cut at 4 μm, and were placed in
stock that had been coated with poly lysine, then were
leaved for around 60 minutes with temperatures of
56.5° – 60° Celsius. Then the 4 μm thick section of
paraffin blocks were deparaffinized in xylen I for
around 5 minutes and xylen II for around 5 minutes,
and rehydrated through a graded series of etanol, after
which they were rinsed shortly tribuffered saline. The
samples section for E-Cadherin staining were incu-
bated with primary antibody of CDH1, Ig I: 200
(DAKO) with solvent 3% NHS for one night and the
samples section for β1-integrin staining were incu-
bated with anti-Human CD29, Ig: 100 (BioGenex) for
one night.
All data were tabulated into the parent table, then
the frequency distribution, median (range), mean, and
standard deviation were calculated. Calculation were
made using Stata, version 7.0. We also performed uni-
variate and bivariate analysis and statistical tests using
simple logistic regression to look for Odd’s ratio, p
< 0.05 was considered to be significant. We per-
formed Spearman and Fisher’s exact test to determine
the correlation of decreased E-Cadherins and β1-inte-
grins expression with the depth of myometrial inva-
sion, degree of differentiation, lymphovascular space
involvement, lymph node metastasis.
Positive immunostaining of E-Cadherin and β1-in-
tegrin expression from endometrial tissue in paraffin
blocks were scored semiquantitatively by two inde-
pendent observers. For semiquantitative analysis of
tumor cells staining, the percentage of positive cell
was noted for approximately 500 cells per slide, sub-
divided into five selected fields at x 400 magnifica-
tion. We used scoring system to assess the staining
intensity of expression E-Cadherin and β1-integrin on
tumor cells. Intensity scores of 0 (no staining) - 3
(maximal staining intensity) were assigned.21
Score 0 : No staining
Skor +1 : the intensity of stained is weak.
Skor +2 : the intensity of stained is moderate.
Skor +3 : the intensity of stained is strong.
A score was calculated as followed;
Score = Σ (i + 1) pi.
i = the intensity of the stained tumor cells.
pi = the percentage of the stained tumor cells for
each intensity varying from 0% to 100%.
The intensity score was multiplied by the percent-
age of positive cells yielding a total staining score of
0 (minimum) - 400 (maximum). Variations between
the observers were below 5%.
Score  00 -  10 : negative expression
Score  11 - 200 : weak expression
Score 201 - 300 : moderate expression
Score 301 - 400 : strong expression
RESULT
A total of 36 patients diagnosed as having endometrial
carcinomas were enrolled in this study, but only 30
paraffin-embedded specimens were used to study the
expression E-Cadherin and β1-integrin using immu-
nohistochemical technique. The median age at diag-
nosis was 52.41 years (range, 30 - 72 years). The dis-
tribution of histological type, tumor stage, histological
grade, and pelvic lymph node metastasis was in ac-
cordance with previously published clinical trials.
(Table 1)
The staining pattern of tumor cells in paraffin
blocks was diffuse and widespread, and almost all of
tumor cells were stained for E-Cadherin and β1-inte-
grin. However, there was clear differences in staining
intensity. Fourteen (46.66%) of tumor cells showed
weak expression of E-Cadherin and β1-integrin, while
eleven (36.67%) of tumor cells showed moderate ex-
pression of E-Cadherin and β1-integrin and five
(16.67%) of tumor cells showed negative expression
of E-Cadherin and β1-integrin. But none of tumor
cells showed strong expression of E-Cadherin and β1-
integrin in this study.
Table 1. Histologic characteristics of the 36 patients with
endometrial cancer.
Histopathology
Characteristics
n = 36
N (%)
Adenocarcinoma
Adenoskuamosa
33
 3
91.67%
 8.33%
Well differentiated
Moderately differentiated
Poorly differentiated
 9
17
10
25%   
47.22%
27.78%
Invasion < 2 myometrium
Invasion ≥ 2 myometrium
13
23
36.11%
63.89%
Negative LVSI
Positive LVSI
17
19
47.22%
52.78%
None peritoneal cytology
Negative peritoneal cytology
 6
21
16.67%
58.33%
Positive peritoneal cytology  9 25%   
Lymp nodes metastasis (-)
Lymp nodes metastasis (+)
25
11
69.44%
30.56%
Cervical stromal invasion
Metastasis to abdominal
None metastasis
 9
10
17
25%   
27.78%
47.22%
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DISCUSSIONS
A total of 30 paraffin-embedded specimens were used
to study the expression E-Cadherin and β1-integrin
using immunohistochemical analysis. Two experi-
enced pathologists blinded to the clinical data re-
viewed all the tumors to confirm the diagnosis and to
determine histologic characteristics. The histologic
grade, the depth of myometrial invasion, and the clini-
cal stage were classified as recommended by the In-
ternational Federation of Gynecology and Obstetrics
(FIGO) of 1995. The staining results were compared
to histologic and clinical data (Table 1).
Endometrial cancer occurs in premenopausal and
postmenopausal women. In this study we found that
the median age at diagnosis was 52.41 years (range,
30 - 72 years). Fifteen (41.67%) patients were pre-
menopausal. The highest incidence occurs between
the ages of 50 - 59 years was 14 (38.89%). The pa-
tients aged over 50 years were 23 (63.89%), the result
of this study was lower than previous study by Creas-
man who reached 90%.28
The number of pascamenopausal women was 21
(58.33%), the result of this study was lower then pre-
vious study in Europe who reached 75%, This is be-
cause the higher life expectancy in developed coun-
Table 2. Odds ratio of cells differentiation with myometrial invasion, LVSI, lymph node metastasis.
n = 36 (p = 0.05).
Grade 1 Grade 1,2 OR (95% CI)
p value
Invasion :
< myometrial
≥ myometrial
7
2
 6
21
12.25 (1.99 - 75.19)
p = 0.007*
LVSI (–)
LVSI (+)
8
1
 9
18
16 (1.72 - 148.41)
p = 0.015*
Lymp nodes (–)
Lymp nodes (+)
7
2
18
 9
1.75 (0.30 - 10.20)
p = 0.534
Table 3. The correlation of E-Cadherin expression with myometrial invasion, LVSI, degree of differentiation, lymph nodes metastasis.
n = 30 (p = 0.05).
E-Cadherin
Negative Weak positive Moderate positive p value (0.05)
Invasion < 2 myometrium
Invasion ≥ 2 myometrium
0
5
 0
14
11
 0
0.001*
Negative LVSI
Positive LVSI
0
5
 4
10
11
 0
0.001*
Well differentiated
Moderately-poorly differentiated
0
5
 2
12
 6
 5
0.045*
Lymp nodes metastasis (-)
Lymp nodes metastasis (+)
0
5
 8
 6
11
 0
0.001*
Table 4. The correlation of β1-integrin expression with myometrial invasion, LVSI, degree of differentiation, lymph nodes metastasis.
n = 30 (p = 0.05).
β1-integrin
Negative Weak positive Moderate positive p value (0.05)
Invasion < 2 myometrium
Invasion ≥ 2 myometrium
0
5
 0
14
11
 0
0.001*
Negative LVSI
Positive LVSI
0
5
 4
10
11
 0
0.001*
Well differentiated
Moderately-poorly differentiated
0
5
 2
12
 6
 5
0.045*
Lymp nodes metastasis (-)
Lymp nodes metastasis (+)
0
5
 8
 6
11
 0
0.001*
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tries and the use of hormone replacement therapy
(HRT). While the number of premenopausal women
was 15 (41.67%), the result of this study was higher
than the study by Hernandes who only reached 25%.22
These results support the theory that the incidence of
endometrial cancer had shifted to younger age. This
becomes a concern because for young patients still
need to maintain their reproductive function.
The mean age of menopausal women was 50.14
years, the result of this study was lower than the study
by Sofian A, but this was in accordance with the study
by Baziad A, which was 50 years old. Further more
these results did not support the theory of late meno-
pause.5
The mean menarche was 13.83 years with a range
between 12 - 15 years. The early menarche was as-
sociated with the high risk of endometrial cancer in-
cidence. This may be attributed to the faster arise me-
narch would be longer exposure to estrogen.29
Theoretically, the use of estrogen increase the in-
cidence of endometrial cancer. However none of the
samples used HRT in the study. This is probably be-
cause the patients of endometrial cancer who came to
the RSUPN Dr. Cipto Mangunkusumo-Jakarta came
from the low socio-economic level which was re-
flected in the low education level. The mean educa-
tional level of endometrial cancer patients was only
6 years (77.78%).
The histopathologic characteristics was shown in
Table 1. The most frequently was endometrioid ade-
nocarcinoma type (91.67%). The result of this study
showed that most endometrial cancer patients were
type I (estrogen dependent) with a better prognosis
than type II (nonestrogen dependent).13
We sometimes found that the histopathology re-
sults of paraffin blocks were different with the his-
topathology results of curettage specimen, especially
the cells type and degree of differentiation. But suit-
ability analysis for histopathology results of paraffin
blocks with histopathology results of curettage speci-
men using a correlation test showed cell type were
0.485 (p = 0.003), meaning that the diagnosis of cell
type from histopathology results of curettage speci-
men were in accordance with the cell type from his-
topathology results of operation specimen, regardless
of the number of specimen that had been sent to the
laboratory. However, the results of correlation test for
degree of differentiation we found was 0.505 (p =
0.201) for curettage specimen < 1cc, 0.378 (p =
0.460) for curettage specimen 1 - 3cc and 0.887 (p =
0.008) for curettage specimen > 3cc. These results
showed that the degree of differentiation from his-
topathology results of operation specimen only in ac-
cordance with histopathology results of curettage
specimen for curettage specimen more than 3cc.
Hence ideally for degree of differentiation and cells
type examination we need curettage specimen more
than 3cc which should be sent to the Department of
Pathology.
We also looked for odds ratio or predictive value
from degree of differentiation to several variables
with logistic regression test (Table 2). The tumor with
moderately-poorly differentiated, the possibility of
myometrial invasion > 50% was 12.25 times (p =
0.007), the possibility of positive LVSI 16 times (p
= 0.015). In this study, the possibility of positive pel-
vic lymph node in moderately-poorly differentiated
was only 1.7 times (p = 0.534). According to statis-
tical calculation which received significant for mod-
erately-poorly differentiated was associated with the
positive myometrial invasion > 50% was 12.25 times
compared to well differentiated and was associated
with the possibility of positive LVSI (lymphovascular
space involvement) was 16 times compared to well
differentiated. But this was not significant for mo-
derately-poorly differentiated associated with the pos-
sibility positive pelvic lymph node metastasis when
we compared to well differentiated.
In Table 3 showed the correlation of E-Cadherin
expression with myometrial invasion, LVSI, degree
of differentiation, lymph node metastasis. The myo-
metrial invasion < 50% were found 11 cases were
moderate positive E-Cadherin expression, in contrast
to myometrial invasion > 50% were found 14 cases
were weak positive E-Cadherin expression and were
found 5 cases were negative E-Cadherin expression,
none of moderate positive E-Cadherin expression. So
the deeper of myometrial invasion would decreased
E-Cadherin expression. In this study we found that
the decreased E-Cadherin expression was associated
with the depth of myometrial invasion > 50% (p =
0.001). In Table 3 showed that all E-Cadherins ex-
pression were negative at the depth of myometrial in-
vasion > 50%. In this study we concluded that E-Ca-
dherin expression can be used as a predictor of the
depth of myometrial invasion.
We found 4 cases were weak positive E-Cadherin
expression, 11 cases were moderate positive E-Cad-
herin expression in negative LVSI. In contrast to posi-
tive LVSI, we found 5 cases were negative E-Cad-
herin expression, 10 cases were weak positive E-Cad-
herin expression and none of moderate positive
E-Cadherin expression. The decreased E-Cadherin ex-
pression was associated with positive LVSI (p = 0.001).
In Table 3 showed that all E-Cadherin expression were
negative in positive LVSI. In this study, we concluded
that E-Cadherin expression can be used as a predictor
of lymphovascular space involvement (LVSI).
We found 2 cases were weak positive E-Cadherin
expression, 6 cases were moderate positive E-Cad-
herin in well differentiated. In contrast to moderately-
poorly differentiated, we found 5 cases were negative
E-Cadherin expression, 12 cases were weak positive
E-Cadherin expression and 5 cases were moderate
positive E-Cadherin expression. The decreased E-
Cadherin expression was associated with moderately-
poorly differentiated (p = 0.001). In Table 3 showed
that all E-Cadherin expression were negative in mod-
erately-poorly differentiated. In this study, we con-
cluded that E-Cadherin expresion can be used as a
predictor of degree of differentiation
In negative lymph node metastasis, we found 8
cases were weak positive E-Cadherin expression and
11 cases were moderate positive E-Cadherin expres-
sion. In contrast to positive lymph node metastasis,
we found 6 cases were weak positive E-Cadherin ex-
pression and 5 cases were negative E-Cadherin ex-
pression. The decreased E-Cadherin expression was
associated with positive lymph node metastasis (p =
0.001). In Table 3 showed that all E-Cadherin expres-
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sion were negative in positive lymph node metastasis.
We concluded in this study that E-Cadherin expres-
sion can be used as a predictor of the depth of lymph
node metastasis.
In Table 4 showed the correlation of β1-integrin
expression with myometrial invasion, lymphovascu-
lar space involvement (LVSI), degree of differentia-
tion, lymph node metastasis. We found 11 cases were
moderate positive β1-integrin expression in the myo-
metrial invasion < 50%. In contrast to the myometrial
invasion > 50%, we found 14 cases were weak posi-
tive β1-integrin expression, 5 cases were negative β1-
integrin expression and none of moderate positived
β1-integrin expression. So the deeper of myometrial
invasion would decreased β1-integrin expression. In
this study we found that the decreased β1-integrin ex-
pression was associated with the depth of myometrial
invasion > 50% (p = 0.001). In this study, we con-
cluded that β1-integrin expression can be used as a
predictor of the depth of myometrial invasion.
We found 4 cases were weak positive β1-integrin
expression, 11 cases were moderate positive β1-inte-
grin expression in negative LVSI. In contrast to posi-
tive LVSI, we found 5 cases were negative β1-inte-
grin expression, 10 cases were weak positive β1-in-
tegrin expression and none of moderate positive
β1-integrin expression. The decreased β1-integrin ex-
pression was associated with positive LVSI (p =
0.001). In Table 4 showed that all β1-integrin expres-
sion were negative in positive LVSI. We can con-
cluded that β1-integrin E-Cadherin expression can be
used as a predictor of the depth of lymphovascular
space involvement.
We found 2 cases were weak positive β1-integrin
expression, 6 cases were moderate positive β1-inte-
grin in well differentiated. In contrast moderately-
poorly differentiated, we found 5 cases were negative
β1-integrin expression, 12 cases were weak positive
β1-integrin expression and 5 cases were moderate
positive β1-integrin expression. The decreased β1-in-
tegrin expression was associated with moderately-
poorly differentiated (p = 0.001). In Table 4 showed
that all β1-integrin expression were negative in mod-
erately-poorly differentiated. We concluded that β1-
integrin expression can be used as a predictor of de-
gree of differentiation.
In negative lymph node metastasis, we found 8
cases were weak positive β1-integrin expression and
11 cases were moderate positive β1-integrin expres-
sion. In contrast to positive lymph nodes metastasis,
we found 6 cases were weak positive β1-integrin ex-
pression and 5 cases were negative β1-integrin ex-
pression. The decreased β1-integrin expression was
associated with positive lymph node metastasis (p =
0.001). In Table 4 showed that all β1-integrin expres-
sion were negative in positive lymph node metastasis.
In this study, we concluded that β1-integrin expres-
sion can be used as a predictor of the depth of lymph
node metastasis.
CONCLUSION
In conclusion, our study support the decreased E-Cad-
herin and β1-integrin expression in resectable en-
dometrial cancer patients were associated with the
depht of myometrial invasion, pelvic lymph node me-
tastasis, lymphovascular space involvement, and de-
gree of differentiation.
SUGGESTIONS
The mayor limitation of our study was the small sam-
ple size. A large number of endometrial cancer sam-
ples is needed for further research on other cell ad-
hesion molecules. However, this study would be im-
portant because these finding clarified the relationship
between cell adhesion molecules with the invasion
and metastatic processes of endometrial cancer.
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